SG11201912651WA - New salt of n-(2,6-diethylphenyl)-8-({4-[4-(dimethylamino)piperidin-1-yl]-2-methoxyphenyl}am ino)-1-methyl-4,5-dihydro-1h-pyrazolo[4,3-h]quinazoline-3-carboxamide, its preparation and formulations containing it - Google Patents

New salt of n-(2,6-diethylphenyl)-8-({4-[4-(dimethylamino)piperidin-1-yl]-2-methoxyphenyl}am ino)-1-methyl-4,5-dihydro-1h-pyrazolo[4,3-h]quinazoline-3-carboxamide, its preparation and formulations containing it

Info

Publication number
SG11201912651WA
SG11201912651WA SG11201912651WA SG11201912651WA SG11201912651WA SG 11201912651W A SG11201912651W A SG 11201912651WA SG 11201912651W A SG11201912651W A SG 11201912651WA SG 11201912651W A SG11201912651W A SG 11201912651WA SG 11201912651W A SG11201912651W A SG 11201912651WA
Authority
SG
Singapore
Prior art keywords
diethylphenyl
ino
pyrazolo
quinazoline
piperidin
Prior art date
Application number
SG11201912651WA
Other languages
English (en)
Inventor
Massimo Zampieri
Marina Caldarelli
Ilaria Candiani
Matteo D'anello
Germano D'arasmo
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of SG11201912651WA publication Critical patent/SG11201912651WA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Inorganic Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
SG11201912651WA 2017-06-29 2018-06-28 New salt of n-(2,6-diethylphenyl)-8-({4-[4-(dimethylamino)piperidin-1-yl]-2-methoxyphenyl}am ino)-1-methyl-4,5-dihydro-1h-pyrazolo[4,3-h]quinazoline-3-carboxamide, its preparation and formulations containing it SG11201912651WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17305826 2017-06-29
PCT/EP2018/067394 WO2019002454A1 (en) 2017-06-29 2018-06-28 NOVEL N- (2,6-DIETHYLPHENYL) -8 - ({4- [4- (DIMETHYLAMINO) PIPERIDIN-1-YL] -2-METHOXYPHENYL} AMINO) -1-METHYL-4,5-DIHYDRO-1H SALT -PYRAZOLO [4,3-H] QUINAZOLINE-3-CARBOXAMIDE, ITS PREPARATION AND FORMULATIONS CONTAINING THE SAME

Publications (1)

Publication Number Publication Date
SG11201912651WA true SG11201912651WA (en) 2020-01-30

Family

ID=59313166

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201912651WA SG11201912651WA (en) 2017-06-29 2018-06-28 New salt of n-(2,6-diethylphenyl)-8-({4-[4-(dimethylamino)piperidin-1-yl]-2-methoxyphenyl}am ino)-1-methyl-4,5-dihydro-1h-pyrazolo[4,3-h]quinazoline-3-carboxamide, its preparation and formulations containing it

Country Status (19)

Country Link
US (3) US11160806B2 (cg-RX-API-DMAC7.html)
EP (1) EP3645535B1 (cg-RX-API-DMAC7.html)
JP (1) JP7141416B2 (cg-RX-API-DMAC7.html)
KR (1) KR102609333B1 (cg-RX-API-DMAC7.html)
CN (1) CN110896636B (cg-RX-API-DMAC7.html)
AR (1) AR112040A1 (cg-RX-API-DMAC7.html)
AU (1) AU2018293729B9 (cg-RX-API-DMAC7.html)
CA (1) CA3068357C (cg-RX-API-DMAC7.html)
CL (1) CL2019003848A1 (cg-RX-API-DMAC7.html)
EA (1) EA039764B1 (cg-RX-API-DMAC7.html)
ES (1) ES2900048T3 (cg-RX-API-DMAC7.html)
IL (1) IL271628B2 (cg-RX-API-DMAC7.html)
MA (1) MA49498A (cg-RX-API-DMAC7.html)
PL (1) PL3645535T3 (cg-RX-API-DMAC7.html)
PY (1) PY1850855A (cg-RX-API-DMAC7.html)
SG (1) SG11201912651WA (cg-RX-API-DMAC7.html)
TW (1) TWI750393B (cg-RX-API-DMAC7.html)
UY (1) UY37778A (cg-RX-API-DMAC7.html)
WO (1) WO2019002454A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025002962A1 (en) 2023-06-30 2025-01-02 Nerviano Medical Sciences S.R.L. Use of a mps1 inhibitor for the treatment of hepatocellular carcinoma
WO2025021587A1 (en) 2023-07-21 2025-01-30 Nerviano Medical Sciences S.R.L. Combination of a mps1 inhibitor and immune checkpoint inhibitors, uses and pharmaceutical compositions thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0914649B1 (pt) * 2008-06-26 2021-07-06 Les Laboratoires Servier Pirazolo-quinazolinas

Also Published As

Publication number Publication date
ES2900048T3 (es) 2022-03-15
MA49498A (fr) 2021-05-26
US11160806B2 (en) 2021-11-02
KR20200020905A (ko) 2020-02-26
IL271628B1 (en) 2023-03-01
AU2018293729B9 (en) 2022-07-14
UY37778A (es) 2019-01-31
US20220016122A1 (en) 2022-01-20
CN110896636A (zh) 2020-03-20
EA202090115A1 (ru) 2020-05-25
KR102609333B1 (ko) 2023-12-01
EP3645535B1 (en) 2021-09-08
PY1850855A (es) 2019-04-01
TW201904971A (zh) 2019-02-01
US20240350501A1 (en) 2024-10-24
JP2020525477A (ja) 2020-08-27
CN110896636B (zh) 2022-07-19
EA039764B1 (ru) 2022-03-11
CL2019003848A1 (es) 2020-07-10
IL271628B2 (en) 2023-07-01
US20200246339A1 (en) 2020-08-06
EP3645535A1 (en) 2020-05-06
AU2018293729B2 (en) 2022-03-10
CA3068357A1 (en) 2019-01-03
WO2019002454A1 (en) 2019-01-03
PL3645535T3 (pl) 2022-03-21
TWI750393B (zh) 2021-12-21
AR112040A1 (es) 2019-09-11
CA3068357C (en) 2022-04-19
JP7141416B2 (ja) 2022-09-22
AU2018293729A1 (en) 2020-01-23
BR112019027924A2 (pt) 2020-08-18
IL271628A (en) 2020-02-27

Similar Documents

Publication Publication Date Title
IL289763A (en) Compounds, pharmaceutical compounds and methods for preparing compounds and their use
IL273852A (en) Preparation and storage of liposomal RNA formulations suitable for treatment
IL267210A (en) Amino acid compounds and methods for treating muscle diseases and disorders
EP3250572A4 (en) Substituted imidazo [1, 2-a]pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereof
CA2956871C (en) Compounds active towards bromodomains
IL281924A (en) New forms of pyrido[1,2-a]pyrimidin-4-one derivatives, its formulation and its process of making
HUE043122T2 (hu) Pirazolo[1,5-a]pirimidin-5,7-diamin vegyületek mint CDK inhibitorok és terápiás alkalmazásuk
WO2016065028A8 (en) Crystalline forms of 5-chloro-n4-[-2-(dimethylphosphoryl) phenyl]-n2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] pyrimidine-2,4-diamine
MX363347B (es) Sal de omecamtiv mecarbilo y proceso para preparar la sal.
HUE063998T2 (hu) Imidazo[4,5-b]piridin vegyületek és azok gyógyászati készítményei gyulladásos betegségek kezelésére
IL274578A (en) Pharmaceutical compounds and preparations thereof for use in the treatment of leiftic diseases
TW201613864A (en) Novel compounds
ZA201708429B (en) Oral solid formulation containing irinotecan and method of preparing the same
PH12016501686A1 (en) Pharmaceutical compositions of sitagliptin
PL3661508T3 (pl) Sposób wytwarzania doustnej postaci dawkowania zawierającej berberynę, doustna postać dawkowania zawierająca berberynę i jej zastosowanie
EA201600318A1 (ru) Циклические тиеноурацилкарбоксамиды и их применение
IL276430A (en) A pharmaceutical compound, its cures, its formulations, and methods for its preparation and use
IL271628A (en) A new salt of N-(6,2-diethylphenyl)-8-({4-[4-(dimethylamino)piperidin-1-yl]-2-methoxyphenyl}amino)-1-methyl-5,4-dihydro-1H -pyrazolo[3,4-H]quinazoline-3-carboxamide, its preparation and formulations containing it
IL265153A (en) 8-(azetidin-1-yl)-[1,2,4]triazolo[1,5-a]pyridinyl compounds, compositions and methods of use thereof
HUE059444T2 (hu) Morfolinszármazék sója és ennek kristályformája, valamint ezek elõállítási eljárása, gyógyszerkészítménye és alkalmazása
WO2017075264A8 (en) Dibenzo azepine compounds and their use in the treatment of otic diseases and disorders
GB201918401D0 (en) Novel crystalline forms of Flufenacet, methods for their preparation and use of the same
WO2016022700A3 (en) Tlr-independent small molecule adjuvants
HK40036525A (en) Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
HK40030474A (en) Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases